Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Hypertension Drug Market by Type (Calcium Channel Blockers, Diuretics, Beta Blockers Vasodilators, Angiotensin Converting Enzyme Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Renin Inhibitors), By Application (Hospital, Private clinic, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Hypertension Drug Market by Type (Calcium Channel Blockers, Diuretics, Beta Blockers Vasodilators, Angiotensin Converting Enzyme Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Renin Inhibitors), By Application (Hospital, Private clinic, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 195849 3300 Pharma & Healthcare 377 234 Pages 4.8 (39)
                                          

The global hypertension drug market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of hypertension and rising awareness about the disease. The major players in this market are AstraZeneca, Novartis, Pfizer, Sanofi-Aventis, Eli Lilly and Company, Merck & Co., Inc, Boehringer Ingelheim GmbH & Co. KG and others.

Some Of The Growth Factors Of This Market:

  1. The aging population is a major factor in the growth of the hypertension drug market.
  2. The increasing prevalence of obesity and diabetes are also factors in the growth of this market.
  3. The increase in chronic kidney disease is another factor that will contribute to the growth of this market, as these patients are at risk for developing hypertension and other cardiovascular diseases, which can lead to an increased need for treatment with antihypertensive drugs.
  4. Increasing awareness about hypertension and its consequences will also contribute to the growth of this market, as it will lead to more people being diagnosed with high blood pressure and subsequently treated with antihypertensive drugs such as ACE inhibitors, beta blockers, calcium channel blockers or diuretics.
  5. Advances in drug development may also contribute to the growth of this market by providing new treatments for hypertension.

Industry Growth Insights published a new data on “Hypertension Drug Market”. The research report is titled “Hypertension Drug Market research by Types (Calcium Channel Blockers, Diuretics, Beta Blockers Vasodilators, Angiotensin Converting Enzyme Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Renin Inhibitors), By Applications (Hospital, Private clinic, Others), By Players/Companies Lupin Limited, Novartis AG, Daiichi - Sankyo, Pfizer Inc, Ranbaxy Laboratories Limited, Sanofi S.A, AstraZeneca Plc, Johnson & Johnson Ltd, Boehringer Ingelheim, Merck & Co.”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Hypertension Drug Market Research Report

By Type

Calcium Channel Blockers, Diuretics, Beta Blockers Vasodilators, Angiotensin Converting Enzyme Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Renin Inhibitors

By Application

Hospital, Private clinic, Others

By Companies

Lupin Limited, Novartis AG, Daiichi - Sankyo, Pfizer Inc, Ranbaxy Laboratories Limited, Sanofi S.A, AstraZeneca Plc, Johnson & Johnson Ltd, Boehringer Ingelheim, Merck & Co.

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

234

Number of Tables & Figures

164

Customization Available

Yes, the report can be customized as per your need.


Global Hypertension Drug Industry Outlook


Global Hypertension Drug Market Report Segments:

The global Hypertension Drug market is segmented on the basis of:

Types

Calcium Channel Blockers, Diuretics, Beta Blockers Vasodilators, Angiotensin Converting Enzyme Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Renin Inhibitors

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Private clinic, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Lupin Limited
  2. Novartis AG
  3. Daiichi - Sankyo
  4. Pfizer Inc
  5. Ranbaxy Laboratories Limited
  6. Sanofi S.A
  7. AstraZeneca Plc
  8. Johnson & Johnson Ltd
  9. Boehringer Ingelheim
  10. Merck & Co.

Global Hypertension Drug Market Overview


Highlights of The Hypertension Drug Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Calcium Channel Blockers
    2. Diuretics
    3. Beta Blockers Vasodilators
    4. Angiotensin Converting Enzyme Inhibitors
    5. Alpha Blockers
    6. Angiotensin Receptor Blockers
    7. Renin Inhibitors
  1. By Application:

    1. Hospital
    2. Private clinic
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Hypertension Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Hypertension Drug Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Hypertension drug is a medication used to lower blood pressure.

Some of the key players operating in the hypertension drug market are Lupin Limited, Novartis AG, Daiichi - Sankyo, Pfizer Inc, Ranbaxy Laboratories Limited, Sanofi S.A, AstraZeneca Plc, Johnson & Johnson Ltd, Boehringer Ingelheim, Merck & Co..

The hypertension drug market is expected to grow at a compound annual growth rate of 4.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Hypertension Drug Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Hypertension Drug Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Hypertension Drug Market - Supply Chain
   4.5. Global Hypertension Drug Market Forecast
      4.5.1. Hypertension Drug Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Hypertension Drug Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Hypertension Drug Market Absolute $ Opportunity

5. Global Hypertension Drug Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Hypertension Drug Market Size and Volume Forecast by Type
      5.3.1. Calcium Channel Blockers
      5.3.2. Diuretics
      5.3.3. Beta Blockers Vasodilators
      5.3.4. Angiotensin Converting Enzyme Inhibitors
      5.3.5. Alpha Blockers
      5.3.6. Angiotensin Receptor Blockers
      5.3.7. Renin Inhibitors
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Hypertension Drug Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Hypertension Drug Market Size and Volume Forecast by Application
      6.3.1. Hospital
      6.3.2. Private clinic
      6.3.3. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Hypertension Drug Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Hypertension Drug Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Hypertension Drug Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Hypertension Drug Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Hypertension Drug Demand Share Forecast, 2019-2026

9. North America Hypertension Drug Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Hypertension Drug Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Hypertension Drug Market Size and Volume Forecast by Application
      9.4.1. Hospital
      9.4.2. Private clinic
      9.4.3. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Hypertension Drug Market Size and Volume Forecast by Type
      9.7.1. Calcium Channel Blockers
      9.7.2. Diuretics
      9.7.3. Beta Blockers Vasodilators
      9.7.4. Angiotensin Converting Enzyme Inhibitors
      9.7.5. Alpha Blockers
      9.7.6. Angiotensin Receptor Blockers
      9.7.7. Renin Inhibitors
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Hypertension Drug Demand Share Forecast, 2019-2026

10. Latin America Hypertension Drug Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Hypertension Drug Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Hypertension Drug Market Size and Volume Forecast by Application
      10.4.1. Hospital
      10.4.2. Private clinic
      10.4.3. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Hypertension Drug Market Size and Volume Forecast by Type
      10.7.1. Calcium Channel Blockers
      10.7.2. Diuretics
      10.7.3. Beta Blockers Vasodilators
      10.7.4. Angiotensin Converting Enzyme Inhibitors
      10.7.5. Alpha Blockers
      10.7.6. Angiotensin Receptor Blockers
      10.7.7. Renin Inhibitors
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Hypertension Drug Demand Share Forecast, 2019-2026

11. Europe Hypertension Drug Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Hypertension Drug Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Hypertension Drug Market Size and Volume Forecast by Application
      11.4.1. Hospital
      11.4.2. Private clinic
      11.4.3. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Hypertension Drug Market Size and Volume Forecast by Type
      11.7.1. Calcium Channel Blockers
      11.7.2. Diuretics
      11.7.3. Beta Blockers Vasodilators
      11.7.4. Angiotensin Converting Enzyme Inhibitors
      11.7.5. Alpha Blockers
      11.7.6. Angiotensin eceptor Blockers
      11.7.7. Renin Inhibitors
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Hypertension Drug Demand Share, 2019-2026

12. Asia Pacific Hypertension Drug Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Hypertension Drug Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Hypertension Drug Market Size and Volume Forecast by Application
      12.4.1. Hospital
      12.4.2. Private clinic
      12.4.3. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Hypertension Drug Market Size and Volume Forecast by Type
      12.7.1. Calcium Channel Blockers
      12.7.2. Diuretics
      12.7.3. Beta Blockers Vasodilators
      12.7.4. Angiotensin Converting Enzyme Inhibitors
      12.7.5. Alpha Blockers
      12.7.6. Angiotensin Receptor Blockers
      12.7.7. Renin Inhibitors
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Hypertension Drug Demand Share, 2019-2026

13. Middle East & Africa Hypertension Drug Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Hypertension Drug Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Hypertension Drug Market Size and Volume Forecast by Application
      13.4.1. Hospital
      13.4.2. Private clinic
      13.4.3. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Hypertension Drug Market Size and Volume Forecast by Type
      13.7.1. Calcium Channel Blockers
      13.7.2. Diuretics
      13.7.3. Beta Blockers Vasodilators
      13.7.4. Angiotensin Converting Enzyme Inhibitors
      13.7.5. Alpha Blockers
      13.7.6. Angiotensin Receptor Blockers
      13.7.7. Renin Inhibitors
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Hypertension Drug Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Hypertension Drug Market: Market Share Analysis
   14.2. Hypertension Drug Distributors and Customers
   14.3. Hypertension Drug Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Lupin Limited
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Novartis AG
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Daiichi - Sankyo
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Pfizer Inc
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Ranbaxy Laboratories Limited
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Sanofi S.A
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. AstraZeneca Plc
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Johnson & Johnson Ltd
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Boehringer Ingelheim
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Merck & Co.
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us